Clinical practice has identified various myositis-specific autoantibodies (MSAs), such as anti-synthetic enzyme antibody and anti-melanoma differentiation associated gene 5 antibody (anti-MDA5 Ab). This evidence concerns the gene IFIH1 and myositis disease.